Composed of leaders in immunology and immuno-oncology, the Scientific Advisory Council guides the Cancer Research Institute's research programs, deciding which promising scientific and medical research proposals will receive CRI funding and support.

Director
James P. Allison, Ph.D.
The University of Texas MD Anderson Cancer Center
Associate Directors
Glenn Dranoff, M.D.
Novartis Institutes for Biomedical Research
Carl F. Nathan, M.D.
Weill Cornell Medicine
Kunle Odunsi, M.D., Ph.D.
The University of Chicago
Ellen Puré, Ph.D.
University of Pennsylvania School of Veterinary Medicine
Robert D. Schreiber, Ph.D.
Washington University School of Medicine
E. John Wherry, Ph.D.
University of Pennsylvania School of Medicine
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
Members
Frederick W. Alt, Ph.D.
Boston Children’s Hospital & Harvard Medical School
Richard Axel, M.D.
Columbia University
Nina Bhardwaj, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Harvey Cantor, M.D.
Dana-Farber Cancer Institute & Harvard Medical School
Jonathan Cebon, Ph.D., FRACP
Olivia Newton-John Cancer Research Institute
Zhijian Chen, Ph.D.
University of Texas Southwestern Medical Center
Max D. Cooper, M.D.
Emory University
Lisa M. Coussens, Ph.D.
Oregon Health and Science University
Peter Cresswell, Ph.D.
Yale University
Jason G. Cyster, Ph.D.
University of California, San Francisco
Mark M. Davis, Ph.D.
Stanford University
Charles G. Drake, M.D., Ph.D.
NewYork-Presbyterian / Columbia University Medical Center
Michael L. Dustin, Ph.D.
University of Oxford
Kate A. Fitzgerald, Ph.D, MRIA
University of Massachusetts Medical School
Richard A. Flavell, Ph.D., FRS
Yale University
Thomas Gajewski, M.D., Ph.D.
The University of Chicago
Laurie H. Glimcher, M.D.
Dana-Farber Cancer Institute
Philip D. Greenberg, M.D.
Fred Hutchinson Cancer Research Center & University of Washington
Nir Hacohen, Ph.D.
Broad Institute of MIT and Harvard
James R. Heath, Ph.D.
Institute for Systems Biology
F. Stephen Hodi, M.D.
Dana-Farber Cancer Institute
Axel Hoos, M.D., Ph.D.
GlaxoSmithKline
Patrick Hwu, M.D.
Moffitt Cancer Center
Darrell J. Irvine, Ph.D.
Massachusetts Institute of Technology
Dirk Jaeger, M.D.
National Center for Tumor Diseases Heidelberg
Elizabeth M. Jaffee, M.D.
Johns Hopkins University School of Medicine
Carl H. June, M.D.
University of Pennsylvania School of Medicine
Susan M. Kaech, Ph.D.
Salk Institute for Biological Studies
Michael Kalos, Ph.D.
Next Pillar Consulting, LLC
Michael Karin, Ph.D.
University of California, San Diego
John M. Kirkwood, M.D.
University of Pittsburgh School of Medicine
Alexander Knuth, M.D.
Hamad Medical Corporation
Lewis L. Lanier, Ph.D.
University of California, San Francisco
Christina S. Leslie, Ph.D.
Memorial Sloan Kettering Cancer Center
Hyam I. Levitsky, M.D.
Century Therapeutics
Ming O. Li, Ph.D.
Memorial Sloan Kettering Cancer Center
Dan R. Littman, M.D., Ph.D.
New York University Medical Center
Nils Lonberg, Ph.D.
Canaan Partners
J. Christopher Love, Ph.D.
Massachusetts Institute of Technology
Tak W. Mak, Ph.D., D.Sc., FRSC
University Health Network
Philippa C. Marrack, Ph.D.
National Jewish Health & University of Colorado
Cornelis J.M. Melief, M.D., Ph.D.
Leiden University Medical Center
Ira Mellman, Ph.D.
Genentech, Inc.
Miriam Merad, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Malcolm A.S. Moore, D.Phil.
Memorial Sloan Kettering Cancer Center
Lee Nadler, M.D.
Harvard Medical School & Dana-Farber Cancer Institute
Drew M. Pardoll, M.D., Ph.D.
Johns Hopkins University School of Medicine
Klaus Rajewsky, M.D.
Max Delbrueck Center for Molecular Medicine
Gwendalyn J. Randolph, Ph.D.
Washington University in St. Louis
Anjana Rao, Ph.D.
La Jolla Institute for Immunology
Antoni Ribas, M.D., Ph.D.
University of California, Los Angeles Comprehensive Cancer Center
Stanley R. Riddell, M.D.
Fred Hutchinson Cancer Research Center & University of Washington
Alexander Rudensky, Ph.D.
Memorial Sloan Kettering Cancer Center
Bijan Safai, M.D., D.Sc.
New York Medical College
Shimon Sakaguchi, M.D., Ph.D.
Osaka University
Lawrence E. Samelson, M.D.
National Cancer Institute, NIH
Hans Schreiber, M.D., Ph.D.
The University of Chicago
Ton N. Schumacher, Ph.D.
The Netherlands Cancer Institute & Leiden University Medical Center
Padmanee Sharma, M.D., Ph.D.
The University of Texas MD Anderson Cancer Center
Craig L. Slingluff Jr., M.D.
University of Virginia Health System
Mark John Smyth, Ph.D., FAHMS
QIMR Berghofer Medical Research Institute
Pramod K. Srivastava, M.D., Ph.D.
University of Connecticut School of Medicine
Susumu Tonegawa, Ph.D.
Massachusetts Institute of Technology
Giorgio Trinchieri, M.D.
National Cancer Institute, NIH
Emil R. Unanue, M.D.
Washington University School of Medicine
Marcel van den Brink, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
Ulrich H. von Andrian, M.D., Ph.D.
Harvard Medical School
Robert H. Vonderheide, M.D., D.Phil.
University of Pennsylvania
Jennifer Wargo, M.D.
The University of Texas MD Anderson Cancer Center
Hao Wu, Ph.D.
Boston Children's Hospital & Harvard Medical School
Kai W. Wucherpfennig, M.D., Ph.D.
Dana-Farber Cancer Institute
Cassian Yee, M.D.
The University of Texas MD Anderson Cancer Center
Rolf M. Zinkernagel, M.D., Ph.D.
University of Zurich
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

This May for Skin Cancer Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to skin cancer.

This May for Brain Tumor Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to cancers of the brain and nervous system. 
Top